|Articles|November 15, 2001
- BioPharm International-11-01-2001
- Volume 14
- Issue 11
Liposomes (a Review), Part One: Manufacturing Issues
by Suggy S. Chrai, R. Murari, and Imran Ahmad Liposomal formulations are increasingly being used in biopharmaceutical development projects. Good manufacturing processes must reproducibly fabricate lipid vesicles that are as uniform in size as possible, carry the drug in sufficient concentration, and remain stable for an acceptable shelf-life under varying temperatures.
Advertisement
Articles in this issue
about 24 years ago
Business Matters: Eclipsed by Catastropheabout 24 years ago
Designs for Bioassays with Plate Location Effectsabout 24 years ago
Simplifying Pharmacologic Analysis with Programmable Scientific Softwareabout 24 years ago
Outsourcing Outlook: Truth in OutsourcingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
2
How Mitigation and Maintenance Protect Against Future Risk
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
Behind the Headlines Episode 29: 2025 Year in Review
5

